These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 113577)

  • 1. High calorie infusion-induced hepatic impairments in infants.
    Hirai Y; Sanada Y; Fujiwara T; Hasegawa S; Kuwabara N
    JPEN J Parenter Enteral Nutr; 1979; 3(3):146-50. PubMed ID: 113577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatic enzyme and bilirubin elevations during parenteral nutrition.
    Grant JP; Cox CE; Kleinman LM; Maher MM; Pittman MA; Tangrea JA; Brown JH; Gross E; Beazley RM; Jones RS
    Surg Gynecol Obstet; 1977 Oct; 145(4):573-80. PubMed ID: 408935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nutrition and hepatic dysfunction.
    Robertson JF; Garden OJ; Shenkin A
    JPEN J Parenter Enteral Nutr; 1986; 10(2):172-6. PubMed ID: 2870203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Alkaline Phosphatase in Infants With Parenteral Nutrition-Associated Liver Disease Reflects Bone Rather Than Liver Disease.
    Nandivada P; Potemkin AK; Carlson SJ; Chang MI; Cowan E; O'Loughlin AA; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):973-6. PubMed ID: 25106918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory monitoring of parenteral nutrition-associated hepatic dysfunction in infants.
    Vileisis RA; Inwood RJ; Hunt CE
    JPEN J Parenter Enteral Nutr; 1981; 5(1):67-9. PubMed ID: 6785477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.
    Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM
    Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercholesterolemia and hypertriglyceridemia as risk factors of liver dysfunction in children with inflammation receiving total parenteral nutrition.
    Golucci APBS; Morcillo AM; Hortencio TDR; Ribeiro AF; Nogueira RJN
    Clin Nutr ESPEN; 2018 Feb; 23():148-155. PubMed ID: 29460791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of 5'-nucleotidase, bilirubin, alkaline phosphatase and transaminase in liver diseases--a comparative study.
    Singh YN; Hameed F; Khan R; Husain Z
    Indian J Pathol Microbiol; 1987 Jan; 30(1):55-67. PubMed ID: 2824355
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic changes during prolonged total parenteral nutrition in intensive care.
    Castelli E; Cetrullo C; Zanello M
    Resuscitation; 1978; 6(4):235-42. PubMed ID: 39324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease.
    Bengoa JM; Hanauer SB; Sitrin MD; Baker AL; Rosenberg IH
    Hepatology; 1985; 5(1):79-84. PubMed ID: 3917969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic complications of parenteral nutrition.
    Bower RH
    Semin Liver Dis; 1983 Aug; 3(3):216-24. PubMed ID: 6414087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
    Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
    J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic diseases. Unsuspected before surgery.
    Wataneeyawech M; Kelly KA
    N Y State J Med; 1975 Jul; 75(8):1278-81. PubMed ID: 1055904
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver in active hyperthyreosis].
    Meng W; Lorenz G; Eggert H; Meng S; Hampel R; Baufeld W
    Z Gesamte Inn Med; 1973 Dec; 28(24):787-91. PubMed ID: 4130587
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition.
    Kim H; Son E; Kim J; Choi K; Kim C; Shin W; Suh O
    Am J Health Syst Pharm; 2003 Sep; 60(17):1760-6. PubMed ID: 14503112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can serum liver function tests differentiate rejection from other causes of liver dysfunction after hepatic transplantation?
    Sankary HN; Williams JW; Foster PF
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):669-70. PubMed ID: 3055469
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.
    Scharer L; Smith JP
    Ann Intern Med; 1969 Dec; 71(6):1113-20. PubMed ID: 5361410
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver disease in infants receiving total parenteral nutrition.
    Postuma R; Trevenen CL
    Pediatrics; 1979 Jan; 63(1):110-5. PubMed ID: 108658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related acute hepatic enzyme elevation: a new disease entity?
    Nachnani JS; Hamid F; Pandya P; Clarkston W; Alba LM
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):378. PubMed ID: 20134262
    [No Abstract]   [Full Text] [Related]  

  • 20. [The general practitioner and abnormal liver function tests].
    Hallez R
    Rev Med Brux; 1997 Sep; 18(4):178-82. PubMed ID: 9411638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.